| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.7 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |